Education
About Us
Working with TipRanks
Follow Us
Therma Bright (TBRIF)
OTHER OTC:TBRIF
TBRIF Stock Chart & Stats
$0.04
<$0.01(2.88%)
At close: 4:00 PM EST
$0.04
<$0.01(2.88%)
Day’s Range― - ―
52-Week Range$0.03 - $0.26
Previous CloseN/A
Volume100.00
Average Volume (3M)4.36K
Market Cap
$2.34M
Enterprise Value$3.21M
Total Cash (Recent Filing)$65.59K
Total Debt (Recent Filing)$40.00K
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Apr 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding58,002,876
10 Day Avg. Volume395
30 Day Avg. Volume4,359
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.51
Price to Sales (P/S)48.92
P/FCF Ratio-26.80
Enterprise Value/Market Cap1.37
Enterprise Value/Revenue42.64
Enterprise Value/Gross Profit127.48
Enterprise Value/Ebitda-0.79
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported DebtLow reported debt materially reduces near-term leverage risk and interest burden, preserving financial flexibility to fund operations or strategic initiatives. Over 2–6 months this lowers default risk and gives management runway to pursue growth or fundraising on better terms.
Positive Gross MarginA positive TTM gross margin (~33%) indicates the company's core products can generate unit-level profitability. If scale is achieved, this margin provides a durable basis for operating leverage, improving operating margins as fixed costs are spread across higher volumes.
Consumables / Recurring Revenue PotentialProduct mix that includes consumable diagnostic tests creates a structural opportunity for recurring revenue and higher customer lifetime value. Durable recurring flows from reorders can stabilize top-line volatility and support margin expansion as installed base and distribution deepen.
Bears Say
Tiny Revenue ScaleExtremely small and declining revenue limits ability to absorb fixed costs, invest in commercialization, and prove product-market fit. Over the medium term this constrains scale benefits from positive gross margins and raises the capital required to reach sustainable profitability.
Persistent Deep LossesLarge recurring losses and negative shareholders' equity reflect accumulated operating deficits that weaken balance sheet resilience. Structurally, this reduces borrowing capacity, increases likelihood of dilutive capital raises, and poses solvency risk if losses persist.
Negative Operating Cash FlowSustained negative OCF/FCF means the business does not self-fund operations or growth and will need external capital. This reliance can dilute shareholders, constrain long-term investment, and make execution on commercialization or scaling plans contingent on successful financing.
Therma Bright News
TBRIF FAQ
What was Therma Bright’s price range in the past 12 months?
Therma Bright lowest stock price was $0.03 and its highest was $0.26 in the past 12 months.
What is Therma Bright’s market cap?
Therma Bright’s market cap is $2.34M.
When is Therma Bright’s upcoming earnings report date?
Therma Bright’s upcoming earnings report date is Apr 07, 2026 which is in 50 days.
How were Therma Bright’s earnings last quarter?
Therma Bright released its earnings results on Dec 01, 2025. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is Therma Bright overvalued?
According to Wall Street analysts Therma Bright’s price is currently Overvalued.
Does Therma Bright pay dividends?
Therma Bright does not currently pay dividends.
What is Therma Bright’s EPS estimate?
Therma Bright’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therma Bright have?
Therma Bright has 58,002,876 shares outstanding.
What happened to Therma Bright’s price movement after its last earnings report?
Therma Bright reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Therma Bright?
Currently, no hedge funds are holding shares in TBRIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Therma Bright
Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.
Technical Analysis
Imagin Medical
―
Perimeter Medical Imaging AI
―
Profound Medical
―
Theralase Technologies
―
Aquarius Surgical Technologies
―